Concepedia

Author

Melinda Smedema

Indiana University School of Medicine

Also Known As

M. L. Smedema, M. Smedema, Melinda L Smedema, Melinda L. Smedema, Melinda Smedema, Melinda L. Smedema

19

Publications

855

Citations

13

H-Index

15

Concepts

All Affiliations

Indiana University School of MedicineIndiana University – Purdue University IndianapolisIndiana UniversityUniversity of Wisconsin–MadisonVeterans Health Administration
MS

About

Melinda Smedema is an author at Indiana University School of Medicine specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

37

2

Pathology

2

2

37

3

Immunology

1

1

11

4

Microbiology

1

1

26

5

Autoimmune Disease

1

1

11

Melinda Smedema

×

15

Publications

823

Citations

13

H-Index

YearCitations

Improved Diagnosis of Acute Pulmonary Histoplasmosis by Combining Antigen and Antibody Detection

Sarah M. Richer, Melinda Smedema, Michelle Durkin,

Clinical Infectious Diseases

2016

110

Comparison of the Echinocandin Caspofungin with Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in a Murine Model

Steve Kohler, L. Joseph Wheat, Patricia Connolly,

Antimicrobial Agents and Chemotherapy

2000

97

Emergence of Resistance to Fluconazole as a Cause of Failure during Treatment of Histoplasmosis in Patients with Acquired Immunodeficiency Disease Syndrome

L. Joseph Wheat, Patricia Connolly, Melinda Smedema,

Clinical Infectious Diseases

2001

94

Does Long-Term Itraconazole Prophylaxis Result in In Vitro Azole Resistance in Mucosal <i>Candida albicans</i> Isolates from Persons with Advanced Human Immunodeficiency Virus Infection?

Mitchell Goldman, Gretchen A. Cloud, Melinda Smedema,

Antimicrobial Agents and Chemotherapy

2000

92

Development of a Highly Sensitive and Specific Blastomycosis Antibody Enzyme Immunoassay Using Blastomyces dermatitidis Surface Protein BAD-1

Sarah M. Richer, Melinda Smedema, Michelle Durkin,

Clinical and Vaccine Immunology

2013

83

Comparison of a New Triazole Antifungal Agent, Schering 56592, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis in Immunocompetent Mice

Patricia Connolly, Joe Wheat, Carol Schnizlein‐Bick,

Antimicrobial Agents and Chemotherapy

1999

76

Comparison of a New Triazole, Posaconazole, with Itraconazole and Amphotericin B for Treatment of Histoplasmosis following Pulmonary Challenge in Immunocompromised Mice

Patricia Connolly, L. Joseph Wheat, Carol Schnizlein‐Bick,

Antimicrobial Agents and Chemotherapy

2000

71

Amphotericin B Combined with Itraconazole or Fluconazole for Treatment of Histoplasmosis

Ann M. LeMonte, Kimberly E. Washum, Melinda Smedema,

The Journal of Infectious Diseases

2000

45

Antifungal Therapy for Central Nervous System Histoplasmosis, Using a Newly Developed Intracranial Model of Infection

Ross R. Haynes, Patricia Connolly, Michelle Durkin,

The Journal of Infectious Diseases

2002

44

Comparison of Nikkomycin Z with Amphotericin B and Itraconazole for Treatment of Histoplasmosis in a Murine Model

Janet Goldberg, Patricia Connolly, Carol Schnizlein‐Bick,

Antimicrobial Agents and Chemotherapy

2000

33

Page 1